Analytic Investors’s AMAG Pharmaceuticals AMAG Stock Holding History

Analytic Investors’s Portfolio AMAG Stock Details AMAG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-8,982	Closed	-$357K	–	701
2015 Q3	$357K	Sell	8,982 -20,043	-69%	-$1.24M	﹤0.01%	485
2015 Q2	$2M	Sell	29,025 -16,616	-36%	-$1.05M	0.03%	278
2015 Q1	$2.5M	Buy	45,641 +1,266	+3%	+$60.3K	0.03%	239
2014 Q4	$1.89M	Buy	+44,375	New	+$1.6M	0.03%	259
2014 Q1	–	Sell	-19,116	Closed	-$464K	–	627
2013 Q4	$464K	Sell	19,116 -9,106	-32%	-$214K	0.01%	394
2013 Q3	$606K	Buy	+28,222	New	+$667K	0.01%	351

Other funds holding AMAG

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Analytic Investors's AMAG Position: Q4 2015 in Review

Analytic Investors sold out of AMAG Pharmaceuticals (AMAG) in Q4 2015, closing a stake of 8,982 shares — an estimated $357K sold.

Analytic Investors first reported a position in AMAG in Q3 2013 and held it in 6 quarters. The position peaked at $2.5M in Q1 2015. 172 funds tracked by Wall St. Rank hold AMAG as of Q4 2015.

Analytic Investors reported no remaining AMAG Pharmaceuticals position as of Q4 2015 after selling out during the quarter.
Analytic Investors sold 8,982 AMAG Pharmaceuticals shares in Q4 2015, an estimated $357K.
Analytic Investors first reported a position in AMAG Pharmaceuticals in Q3 2013 and held it in 6 quarters.
Analytic Investors's AMAG Pharmaceuticals position peaked at $2.5M in Q1 2015.
172 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q4 2015.

Based on Analytic Investors's 13F filing for Q4 2015, filed 12 Feb 2016.